caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1992701908

Xudong XuM.D.

PRACTICEWELCOME FAMILY MEDICINE, PASee all providers at this practice →
Family PracticeHouston, TXI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Xudong Xu's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 8 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Clinical Pathology Laboratories, Inc.
Clinical Laboratory · Austin, TX
156482
Yongfang Chen
Family Practice · Houston, TX
80245
Quest Diagnostics Clinical Laboratories Inc
Clinical Laboratory · Houston, TX
56132
Jianwei Feng
Cardiology · Houston, TX
2983
Steven Yong
Cardiology · Houston, TX
2153
Victor Yang
Gastroenterology · Houston, TX
2159
UNIVERSITY OF TEXAS M. D. ANDERSON CANCER CENTER1348
Memorial Hermann Surgery Center Southwest Llp
Ambulatory Surgical Center · Houston, TX
1116
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
655
Unique beneficiaries
—
Total services
2,747
Distinct HCPCS
10
Medicare payment
$127K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 6,385 Family Practice providers in TX — top quintile (cohort median 567).
PRESCRIBING · PART D · 2024
Total Rx claims
19,079
Beneficiaries
—
Total drug cost
$3.4M
Distinct drugs
179
Brand share
29.6%
Top prescribed drugs
Icosapent Ethyl1,041 claims
Atorvastatin Calcium863 claims
Rosuvastatin Calcium686 claims
Amlodipine Besylate529 claims
Levocetirizine Dihydrochloride511 claims
QUALITY · MIPS · 2024
No data available for this provider in 2024.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$5K
Payment records
155
By payment type
Food and Beverage$5K